SEC Form 4 · accession 0000882104-15-000052
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter S Garcia
Officer — Vice President, CFO
Period of report
Aug 13, 2015
Accepted (ET)
Aug 17, 2015 · 6:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Aug 13, 2015 | P | 7,800 | $5.8599 | A | 83,672 | D | |
| Common stock | Aug 13, 2015 | P | 2,200 | $5.86 | A | 85,872 | D | |
| Common stock | Aug 14, 2015 | P | 2,400 | $5.7899 | A | 88,272 | D | |
| Common stock | Aug 14, 2015 | P | 7,300 | $5.79 | A | 95,572 | D | |
| Common stock | Aug 14, 2015 | P | 300 | $5.80 | A | 95,872 | D |
Table II — derivative securities
No Table II lines on this filing.